The environment‐pathogen‐host axis in communicable and non‐communicable diseases: Recent advances in experimental and clinical research
- 3 May 2014
- journal article
- review article
- Published by Wiley in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
- Vol. 12 (5) , 395-399
Abstract
Allergies and autoimmune diseases are spreading worldwide. Control of infections, on the other hand, remains an issue, even in the post-antibiotic era. Chronic or poorly controlled infections occur in immune compromised individuals such as HIV patients, hospitalized patients exposed to multi-resistant bacteria, or patients on immunosuppressive treatment. They may become an even more emerging issue in an ageing population. At the same time, profound environmental changes such as global warming, urbanization, increasing environmental pollution and novel food engineering technologies may alter the abundance or aggressiveness of allergens/allergen carriers in our environment. Likewise, changes in dietary habits - and possibly also use of antibiotics - have an impact on the composition of our natural microbial flora in the gut, airways and skin, which may alter susceptibility for common diseases, among them allergies, asthma and atopic eczema. At the recently founded Institute of Environmental Medicine of the Technische Universität Munich, located in Augsburg at the UNIKA-T, experimental, clinical and translational research is focused on the complex interactions of environment, pathogen and host in expression or control of communicable and non-communicable diseases. We present our research concept and recent findings in environment - host interactions.Keywords
This publication has 21 references indexed in Scilit:
- Davos Declaration: Allergy as a global problemAllergy, 2012
- Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasisJournal of Experimental Medicine, 2011
- Chronic mucocutaneous candidiasis, from bench to bedsideEuropean Journal Of Dermatology, 2010
- Pollen allergens do not come alone: pollen associated lipid mediators (PALMS) shift the human immue systems towards a TH2-dominated responseAllergy, Asthma & Clinical Immunology, 2009
- Patients with Chronic Mucocutaneous Candidiasis Exhibit Reduced Production of Th17-Associated Cytokines IL-17 and IL-22Journal of Investigative Dermatology, 2008
- Altered, but not diminished specific T cell response in chronic mucocutaneous candidiasis patientsArchives of Dermatological Research, 2007
- Year-to-Year Variation in Release of Bet v 1 Allergen from Birch Pollen: Evidence for Geographical Differences between West and South GermanyInternational Archives of Allergy and Immunology, 2007
- Chemotaxis and activation of human peripheral blood eosinophils induced by pollen-associated lipid mediatorsJournal of Allergy and Clinical Immunology, 2004
- Environmental Exposure to Endotoxin and Its Relation to Asthma in School-Age ChildrenNew England Journal of Medicine, 2002
- Lipid mediators from pollen act as chemoattractants and activators of polymorphonuclear granulocytesJournal of Allergy and Clinical Immunology, 2002